Granted Patent
B2
US 8,440,815 · App. 12/601,896 · Granted May 14, 2013
Pneumococcal serotype 6D
Assignee:
UAB Research Foundation
View Patent ↗
Loading inventors, assignments & file history…
Abstract
Disclosed is a new and emerging serotype of Streptococcus pneumoniae designated serotype 6D, and assays and monoclonal antibodies useful in identifying same. Also disclosed is a novel pneumococcal polysaccharide with the repeating unit →2) glucose 1 (1→3) glucose 2 (1→3) rhamnose (1→4) ribitol (5→phosphate. This new serotype may be included in pneumococcal vaccines.
Claims (1)
1. A purified polysaccharide comprising the repeating unit {→2) glucose 1 (1→3) glucose 2 (1→3) rhamnose (1→4) ribitol (5→phosphate}.
Assignments (2)
CONFIRMATORY LICENSE
Recorded Aug 24, 2021
From: UNIVERSITY OF ALABAMA AT BIRMINGHAM
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 057278/0808 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Dec 4, 2012
From: NAHM, MOON H.; PARK, IN HO, PHD.
To: UAB RESEARCH FOUNDATION
Reel/Frame 029398/0637 →
Continuity (3)
Provisional Application
60924703
· May 29, 2007
Provisional Application
60924704
· May 29, 2007